U.S. Court of Appeals for the Federal Circuit, 2019

Amgen Inc. v. Sandoz Inc.

Amgen Inc. v. Sandoz Inc.
U.S. Court of Appeals for the Federal Circuit · Decided September 3, 2019

Amgen Inc. v. Sandoz Inc.

Opinion

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ AMGEN INC., AMGEN MANUFACTURING, LIMITED, Plaintiffs-Appellants v. SANDOZ INC., SANDOZ INTERNATIONAL GMBH, SANDOZ GMBH, Defendants-Appellees ______________________ 2018-1551 ______________________ Appeal from the United States District Court for the Northern District of California in No. 3:14-cv-04741-RS, Judge Richard Seeborg.

------------------------------------------------------ AMGEN INC., AMGEN MANUFACTURING, LIMITED, Plaintiffs-Appellants v. SANDOZ INC., SANDOZ INTERNATIONAL GMBH, SANDOZ GMBH, LEK PHARMACEUTICALS, D.D., Defendants-Appellees ______________________ 2 AMGEN INC. v. SANDOZ INC.

2018-1552 ______________________ Appeal from the United States District Court for the Northern District of California in No. 3:16-cv-02581-RS, Judge Richard Seeborg. ______________________ ON PETITION FOR PANEL REHEARING ______________________ Before LOURIE, O’MALLEY, and REYNA, Circuit Judges.

PER CURIAM.

ORDER Appellants filed a petition for panel rehearing on June 7, 2019. A response to the petition was invited by the panel and filed by the Appellees on July 29, 2019.

Upon consideration thereof, IT IS ORDERED THAT: 1) The petition for panel rehearing is GRANTED to the extent that the following portion of the opinion at page 11, lines 20–21, is removed: applies only in exceptional cases and 2) The petition for panel rehearing is otherwise DENIED.

FOR THE COURT September 3, 2019 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.